↓ Skip to main content

Readers on

mendeley
75 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Are Prophylactic and Therapeutic Target Concentrations Different?: the Case of Lopinavir-Ritonavir or Lamivudine Administered to Infants for Prevention of Mother-to-Child HIV-1 Transmission during Breastfeeding
Published in
Antimicrobial Agents and Chemotherapy, January 2017
DOI 10.1128/aac.01869-16
Pubmed ID
Authors
Abstract

The ANRS 12174 trial assessed the efficacy and tolerance of LPV/r versus 3TC prophylaxis administered to breastfed infants, whose HIV-infected mothers were not on ART. In this sub-study, we assessed LPV/r and 3TC pharmacokinetics to evaluate the percentage of infants with therapeutic plasma concentrations and to discuss these data in the context of a prophylactic treatment. Infants from the South African trial site underwent blood sampling for pharmacokinetic study at week 6, 26 and 38 of life. We applied a Bayesian approach to derive the 3TC and LPV pharmacokinetic parameters based on previously published pharmacokinetic models for HIV-infected children. We analyzed 114 LPV and 180 3TC plasma concentrations from 69 infants and 92 infants, respectively. A total of 30 LPV and 20 3TC observations were considered as missing doses and discarded from Bayesian analysis. The overall population analysis shows that 30 to 40% of infants did not reach therapeutic targets, regardless of treatment group. Median[IQR] LPV Ctrough at week 6, 26 and 38 were 2.8[1.7-4.4], 5.6[3.2-7.7] and 3.4[2.3-7.3] mg/L, respectively. Median[IQR] 3TC AUC0-12 were 5.6[4.1-7.8], 5.9[5.1-7.5] and 7.3[4.9-8.5] mg.h/Lat week 6, 26 and 38, respectively. The therapeutic doses recommended by the WHO would have resulted in a higher proportion of infants achieving the targets. However, no HIV-1 infection was reported among these infants. These results suggest that the prophylactic targets for both 3TC and LPV may be lower than the therapeutic ones. For treatment, the WHO dosing guidelines should be suitable to maintain most infants above therapeutic pharmacokinetic targets.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 75 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 75 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Master 10 13%
Researcher 10 13%
Student > Bachelor 7 9%
Student > Doctoral Student 5 7%
Other 4 5%
Other 12 16%
Unknown 27 36%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 20 27%
Nursing and Health Professions 10 13%
Agricultural and Biological Sciences 3 4%
Biochemistry, Genetics and Molecular Biology 2 3%
Business, Management and Accounting 2 3%
Other 8 11%
Unknown 30 40%